| EMD 534085 |
N-[2-(二甲基氨基)乙基]-N'-[[(2R,4AS,5R,10BS)-3,4,4A,5,6,10B-六氢-5-苯基-9-(三氟甲基)-2H-吡喃并[3,2-C]喹啉-2-基]甲基]脲 |
858668-07-2 |
| N-[2-[(3S)-3-[[4-Hydroxy-4-[5-(pyrimidin-2-yl)pyridin-2-yl]cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
N-[2-[(3S)-3-[[4-羟基-4-[5-(嘧啶-2-基)吡啶-2-基]环己基]氨基]吡咯烷-1-基]-2-氧代乙基]-3-(三氟甲基)苯甲酰胺 |
857679-55-1 |
| (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one |
PONESIMOD |
854107-55-4 |
| Naloxegol |
NALOXEGOL |
854601-70-0 |
| TP808 |
TP808 |
852821-06-8 |
| N-[4-[5-(1,3-BENZODIOXOL-5-YL)-3-METHOXY-1H-1,2,4-TRIAZOL-1-YL]PHENYL]-2-(PHENYLTHIO)ACETAMIDE |
CS-2379 |
853625-60-2 |
| Galeterone |
Galeterone |
851983-85-2 |
| Seladelpar |
MBX 8025 |
851528-79-5 |
| OC000459 |
[5-氟-2-甲基-3-(喹啉-2-基甲基)吲哚-1-基]乙酸 |
851723-84-7 |
| GSK269962A |
N-[3-[[2-(4-氨基呋咱-3-基)-1-乙基-1H-咪唑并[4,5-C]吡啶-6-基]氧]苯基]-4-[[2-(4-吗啉基)乙基]氧]苯甲酰胺 |
850664-21-0 |
| PDK1 Inhibitor |
PDK1 INHIBITOR |
850717-64-5 |
| BIIB-021 |
BIIB021/CNF2024 |
848695-25-0 |
| 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
5-氯-6-[2,6-二氟-4-[3-(甲基氨基)丙氧基]苯基]-N-((1S)-2,2,2-三氟-1-甲基乙基)-[1,2,4]三唑并[1,5-A]嘧啶-7-胺 |
849550-05-6 |
| PTACH |
NCH-51 |
848354-66-5 |
| AZD 9668 |
ALVELESTAT |
848141-11-7 |
| Pemafibrate |
佩玛贝特 |
848259-27-8 |
| SHA 68 |
SHA 68 |
847553-89-3 |
| NVP-BEP800 |
NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE |
847559-80-2 |
| Auriclosene |
Auriclosene |
846056-87-9 |
| ML385 |
ML385 |
846557-71-9 |
